Glutathione S-transferase pi (GST-pi) inhibition and anti-inflammation activity of the ethyl acetate extract of Streptomyces sp. strain MJM 8637

[1]  C. Wild.  Cancer control: a reminder of the need for a balanced approach between prevention and treatment. , 2014, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[2]  Shan Li,et al.  Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis , 2014, BMC Medicine.

[3]  Koichiro Tamura,et al.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.

[4]  Aidan C. Parte,et al.  LPSN—list of prokaryotic names with standing in nomenclature , 2013, Nucleic Acids Res..

[5]  Samiuela Lee,et al.  Antioxidant and anti-inflammatory activities of selected medicinal plants and fungi containing phenolic and flavonoid compounds , 2012, Chinese Medicine.

[6]  Xi-jun Wang,et al.  Future perspectives of Chinese medical formulae: chinmedomics as an effector. , 2012, Omics : a journal of integrative biology.

[7]  K. Tiwari,et al.  Rare actinomycetes: a potential storehouse for novel antibiotics , 2012, Critical reviews in biotechnology.

[8]  G. Grau,et al.  Microparticles and their emerging role in cancer multidrug resistance. , 2012, Cancer treatment reviews.

[9]  D. Backos,et al.  The role of glutathione in brain tumor drug resistance. , 2012, Biochemical pharmacology.

[10]  G. Münch,et al.  Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds. , 2011, Journal of agricultural and food chemistry.

[11]  F. Gao,et al.  Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines. , 2011, Oncology reports.

[12]  Y. Zeng,et al.  Multidrug resistance-associated biomarkers PGP, GST-π, Topo-II and LRP as prognostic factors in primary ovarian carcinoma , 2011, British journal of biomedical science.

[13]  R. Houlgatte,et al.  Inhibition of GST-pi nuclear transfer increases mantle cell lymphoma sensitivity to cisplatin, cytarabine, gemcitabine, bortezomib and doxorubicin. , 2010, Anticancer research.

[14]  E. Laborde.  Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death , 2010, Cell Death and Differentiation.

[15]  S. Mazumdar,et al.  INFLUENCE OF NUTRITION AND CULTURING CONDITIONS FOR OPTIMUM GROWTH AND ANTIMICROBIAL METABOLITE PRODUCTION BY STREPTOMYCES SP. 201 , 2009 .

[16]  A. García-Lafuente,et al.  Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease , 2009, Inflammation Research.

[17]  J. Wastling,et al.  Thiazolides inhibit growth and induce glutathione‐S‐transferase Pi (GSTP1)‐dependent cell death in human colon cancer cells , 2008, International journal of cancer.

[18]  W. Muiru,et al.  Identification of Selected Actinomycete Isolates and Characterization of Their Antibiotic Metabolites , 2008 .

[19]  D. Whitworth,et al.  Myxobacteria : multicellularity and differentiation , 2007 .

[20]  Lin Chen,et al.  Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Mukanganyama,et al.  Inhibition of glutathione S‐transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance , 2002, International journal of cancer.

[22]  Mengcheng Tang,et al.  The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals , 1999 .

[23]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[24]  L. Packer,et al.  The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. , 1994, Biochemical and biophysical research communications.

[25]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[26]  J. Felsenstein.  CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP , 1985, Evolution; international journal of organic evolution.

[27]  M. Nei,et al.  Estimation of evolutionary distance between nucleotide sequences. , 1984, Molecular biology and evolution.

[28]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[29]  F. Arcamone,et al.  Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius , 1969, Biotechnology and bioengineering.

[30]  M. Shibata,et al.  Studies on Streptomycetes , 1969 .

[31]  T. Takeuchi,et al.  New antibiotics, bleomycin A and B. , 1966, The Journal of antibiotics.

[32]  E. B. Shirling,et al.  Methods for characterization of Streptomyces species , 1966 .

[33]  J. Fulton,et al.  The Actinomycetes , 1951, The Yale Journal of Biology and Medicine.

[34]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[35]  J. Wan,et al.  Rationale for the Use of Natural Anti-Inflammatory Agents in Cancer Chemotherapy , 2010 .

[36]  Robert Edwards,et al.  Glutathione Transferases , 2010, The arabidopsis book.

[37]  Ruiwen Zhang,et al.  Anti-Inflammatory Agents for Cancer Therapy. , 2009, Molecular and cellular pharmacology.

[38]  M. Buttner,et al.  24 Multicellular Development in Streptomyces , 2008 .

[39]  L. Hofseth,et al.  Identifying and defusing weapons of mass inflammation in carcinogenesis. , 2006, Biochimica et biophysica acta.

[40]  P. Kämpfer.  The Family Streptomycetaceae, Part I: Taxonomy , 2006 .

[41]  J. Euzéby.  List of prokaryotic names with standing in nomenclature-genus Roseomonas , 2006 .

[42]  W. Pearson,et al.  Nomenclature for mammalian soluble glutathione transferases. , 2005, Methods in enzymology.

[43]  M. Gottesman.  Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.

[44]  T. Kieser.  Practical streptomyces genetics , 2000 .

[45]  D. Lane.  16S/23S rRNA sequencing , 1991 .

[46]  M. Oyaizu.  Studies on products of browning reaction--antioxidative activities of products of browning reaction prepared from glucosamine , 1986 .

[47]  H. Lechevalier,et al.  Biology of actinomycetes. , 1967, Annual review of microbiology.

[48]  D. Gottlieb.  An evaluation of criteria and procedures used in the description and characterization of the Streptomycetes. A cooperative study. , 1961, Applied microbiology.